That agrees with what has been reported earlier [53], where BCP-oxide was found to reduce STAT3 level in MM, prostate and breast cancer cell lines via upregulation of the tyrosine phosphatase, SHP-1, and by inhibiting the kinases, JAK1/2, and their downstream target, STAT3. Here, STAT3 is linked to Miyoshi myopathy.